Search results
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 1 day agoThe company will be running three trials with EXL01, but the...in the treatment arm will receive...
Bristol Myers posts quarterly loss, lays out $1.5 billion cost-saving plan
Reuters via Yahoo Finance· 2 days ago(Reuters) -Bristol Myers Squibb reported a first-quarter loss on Thursday as charges related to its...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 2 days agoBristol Myers’ cuts come after a first quarter during which several of its prized new medicines...
Bristol Myers posts quarterly loss, revenue rises 5%
KFGO· 2 days agoBy Deena Beasley (Reuters) - Bristol Myers Squibb on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics ...
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Zacks via Yahoo Finance· 5 days agoIncreased sales of the key immuno-oncology drug Opdivo on consistent label expansions for newer...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 1 day agoTotal sales of the immuno-oncology drug Opdivo, approved for multiple cancer indications, went down...
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 2 days agoBristol-Myers' (BMY) first-quarter 2024 loss is narrower than estimated. Sales surpass the consensus...
Bristol-Myers Cuts '24 EPS View, Posts Narrower-Than-Seen 1Q Loss
Morningstar· 2 days agoBy Rob Curran Bristol-Myers Squibb cut its 2024 earnings projection even as the drug giant posted a narrower-than-anticipated first-quarter loss, reflecting the impact of ...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 3 days agoBristol Myers’ revenues in the first quarter of 2024 are likely to have been boosted by the sales...
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoToday, we are seeing the inventory patterns for Opdivo and Camzyos normalizing. And for Sotyktu,...
